MoneyWorks4Me

Alkem Laboratories to make equity investment in Sunsure Solarpark

18 Dec 2024 Evaluate

Alkem Laboratories together with its subsidiary M/s. Enzene Biosciences (Enzene) has entered into a Share Subscription and Shareholders’ agreement on December 17, 2024 with M/s. Sunsure Solarpark Twenty Two (Sunsure Solarpark) and M/s. Sunsure Energy for equity investment in Sunsure Solarpark. The said investment will be completed by the end of April, 2025. 

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Peers
Company Name CMP
Sun Pharma. Inds. 1781.00
Dr. Reddys Labs. 1200.30
Cipla 1335.00
Lupin 2014.00
Zydus Lifesciences 1141.80
View more..